Investors eager to jump on a surging initial public offering should pause before making a day-one purchase. SpaceX stock dropped beneath its $135 IPO valuation just 34 days following its market debut, while Anthropic appears poised to breach that critical marker even faster, with shares hovering remarkably close to its $83 initial price point during opening trades. For everyday retail participants, the primary takeaway isn't about the long-term viability of these enterprises, but rather the entry price paid for ownership. When market mania peaks, allowing initial volatility and hype to subside frequently creates a far more attractive acquisition window.

The Machinery Behind IPO Marketing

Significant, calculated effort goes into framing public offerings as monumental and exceptionally valuable financial events. This heavy lifting falls to the underwriting banks retained to manage the rollout. A corporation pursuing an initial public offering aims to secure capital for strategic expansion while simultaneously providing liquidity and anticipated returns to early-stage backers.

As massive volumes of stock change hands, sellers seek to offload remaining inventory to institutional buyers and, crucially, to retail participants who may feel they are securing an exclusive opportunity at an inflated cost.

Promoting an offering is a standard practice, but the intensity of the hype deployed by corporations and financial institutions is designed to extract capital from retail traders. Conversely, institutional entities leverage dedicated experts, exhaustive research, and deep resources to navigate these decisions. Furthermore, large institutions maintain sufficient capital and perspective to absorb losses, effectively hedging their exposure.

Most individual investors lack these sophisticated safety nets, leaving them significantly more vulnerable to expert marketing and persuasion tactics.

Why Patience Pays Off In Public Offerings

Market veterans often advise buyers to wait for a downward correction, and when applied to heavily hyped IPOs, this strategy holds considerable merit.

During the week SpaceX shares dipped below their initial valuation, an analysis by The Motley Fool examining ten major public debuts—including Rivian Automotive and Coupang—revealed that eight experienced price contractions within three months of launching. Five of those issues suffered double-digit losses, registering an average three-month decline of 13%.

For SpaceX, the baseline valuation was established at $135, yet the equity has frequently traded below that threshold. Average retail buyers rarely secure shares at the official baseline due to premiums ranging from 10% to 20% or higher. The architects of the offering strive to engineer an initial pop, enabling insiders to lock in early gains should they be cleared to sell.

However, underwriters never price an offering expecting an immediate collapse. By 1:50 p.m. Eastern time, Anthropic shares traded tightly between $84.50 and slightly above $87, after briefly touching $83.87 at 11:44 a.m.

This tight range places the equity squarely at risk of matching or falling below its opening valuation.

Realities When Stocks Breach Initial Valuations

While atypical, shares slipping beneath their IPO price is far from unprecedented. Historical market data confirms this phenomenon recurs across various economic cycles.

Gaming pioneer Zynga experienced an approximate 10% valuation drop during its first trading session. Similarly, tech giants and consumer brands like Meta, Uber, Robinhood, and Peloton all finished their debut days underwater.

Decades of academic and institutional research have routinely questioned the wisdom of chasing initial public offerings. For instance, an August 2019 study by Dimensional Fund Advisors analyzed 6,362 American IPOs spanning January 1991 to December 2018, concluding that public debuts historically underperform broader market benchmarks and exhibit fundamental traits pointing toward diminished expected returns.

While many represented smaller firms, consistent outperformance remains an unreliable expectation. Investors must remain cognizant of adverse selection risks and post-offering catalysts, including the eventual expiration of insider lockup restrictions.